Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1817713 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $15.58Day +4.14%Mkt cap $950M1Y −35.7%Off 52W high −55.9%Vol (1Y) 74.6%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,283 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest10.6% of sh out |
| Days to cover6.4d |
| 13F net flow (QoQ)−5.93% |
| Top-10 13F concentration60.7% |
| Next report (est.)2026-08-06 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$13.7M |
| Earnings (TTM)-$114.5M |
| ROE−11.5% |
| Net margin−1136.3% |
| Sales growth 3Y5.1% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+12.9% |
| 1Y−35.7% |
| 3Y+11.3% |
| 5Y−52.0% |
| Since incept. (ann.)−4.9% |
Total return through 2026-07-30 · series begins 2021-06-14. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)74.6% |
| Ann. volatility (3Y)154.6% |
| Sharpe (1Y)−0.11 |
| Sharpe (3Y)0.47 |
| Max drawdown (1Y)−64.9% |
| Max drawdown (3Y)−81.8% |
| Beta (3Y vs SPY)3.64 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11.2M | $156M | 18.39% | +0.0% |
| BlackRock, Inc. | 5.4M | $76M | 8.93% | +33.2% |
| JANUS HENDERSON GROUP PLC | 4.2M | $58M | 6.90% | −21.6% |
| Prosight Management, LP | 3.5M | $49M | 5.84% | +48.4% |
| FMR LLC | 2.5M | $35M | 4.17% | −27.8% |
| STATE STREET CORP | 2.5M | $34M | 4.05% | −36.1% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | $25M | 2.98% | new |
| TCG Crossover Management, LLC | 1.8M | $25M | 2.94% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$0.39 | — | $3.7M | — |
| 2025-12-31 | 2026-02-26 | — | — | $0 | — |
| 2025-09-30 | 2025-11-06 | −$0.39 | — | $10.0M | +2177.9% |
| 2025-06-30 | 2025-08-07 | −$0.55 | — | $0 | −100.0% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
